Cost-effectiveness of liver cancer screening

被引:37
作者
Cucchetti, Alessandro [1 ]
Cescon, Matteo [1 ]
Erroi, Virginia [2 ]
Pinna, Antonio D. [1 ]
机构
[1] Univ Bologna, Gen Surg & Transplant Unit, Dept Med & Surg Sci DIMEC, S Orsola Malpighi Hosp,Alma Mater Studiorum, I-40138 Bologna, Italy
[2] Univ Bologna, Div Semeiot, Dept Med & Surg Sci DIMEC, S Orsola Malpighi Hosp,Alma Mater Studiorum, I-40138 Bologna, Italy
关键词
Liver cancer; Hepatocellular carcinoma; Surveillance; Cost-effectiveness; Prevention & control; Cost-benefit; Cirrhosis; Screening; RANDOMIZED CONTROLLED-TRIAL; HEPATOCELLULAR-CARCINOMA SURVEILLANCE; CIRRHOTIC-PATIENTS; RISK-FACTORS; SEMIANNUAL SURVEILLANCE; MULTIVARIATE-ANALYSIS; RECOMMENDATIONS; DIAGNOSIS; PROGRAM;
D O I
10.1016/j.bpg.2013.08.021
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Screening for primary liver cancer means surveillance for hepatocellular carcinoma (HCC), which is one of the most common cancers worldwide. Detection of HCC for curative treatment is increased by surveillance, but target population, optimal periodicity and cost-effectiveness aspects are still debated issues. The aim of surveillance is to obtain a reduction in HCC-related mortality and this is usually achieved through an early diagnosis that increases both applicability and cost-effectiveness of curative treatments. The aim of the present review is to analyse economic aspects of HCC surveillance. Articles that assessed cost-effectiveness of surveillance for HCC, published between 1996 and February 2013, were reviewed in order to verify the cost-effectiveness of surveillance, its optimal periodicity, the target population and the role of alternative surveillance strategies. International guidelines are currently based on the results of such cost-effectiveness analyses, highlighting the importance of the release of cost-effectiveness-guided guidelines for HCC management. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:961 / 972
页数:12
相关论文
共 43 条
[1]
Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis [J].
Andersson, Karin L. ;
Salomon, Joshua A. ;
Goldie, Sue J. ;
Chung, Raymond T. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (12) :1418-1424
[2]
[Anonymous], 1996, COST EFFECTIVENESS H, DOI DOI 10.1093/OSO/9780195108248.001.0001
[3]
[Anonymous], SEER STAT DAT INC SE
[4]
Arguedas MR, 2003, AM J GASTROENTEROL, V98, P679, DOI 10.1111/j.1572-0241.2003.07327.x
[5]
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace [J].
Baffy, Gyoergy ;
Brunt, Elizabeth M. ;
Caldwell, Stephen H. .
JOURNAL OF HEPATOLOGY, 2012, 56 (06) :1384-1391
[6]
NATURAL-HISTORY OF SMALL UNTREATED HEPATOCELLULAR-CARCINOMA IN CIRRHOSIS - A MULTIVARIATE-ANALYSIS OF PROGNOSTIC FACTORS OF TUMOR-GROWTH RATE AND PATIENT SURVIVAL [J].
BARBARA, L ;
BENZI, G ;
GAIANI, S ;
FUSCONI, F ;
ZIRONI, G ;
SIRINGO, S ;
RIGAMONTI, A ;
BARBARA, C ;
GRIGIONI, W ;
MAZZIOTTI, A ;
BOLONDI, L .
HEPATOLOGY, 1992, 16 (01) :132-137
[7]
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis [J].
Bolondi, L ;
Sofia, S ;
Siringo, S ;
Gaiani, S ;
Casali, A ;
Zironi, G ;
Piscaglia, F ;
Gramantieri, L ;
Zanetti, M ;
Sherman, M .
GUT, 2001, 48 (02) :251-259
[8]
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].
Bruix, J ;
Sherman, M ;
Llovet, JM ;
Beaugrand, M ;
Lencioni, R ;
Burroughs, AK ;
Christensen, E ;
Pagliaro, L ;
Colombo, M ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430
[9]
Management of Hepatocellular Carcinoma: An Update [J].
Bruix, Jordi ;
Sherman, Morris .
HEPATOLOGY, 2011, 53 (03) :1020-1022
[10]
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma [J].
Camma, Calogero ;
Cabibbo, Giuseppe ;
Petta, Salvatore ;
Enea, Marco ;
Iavarone, Massimo ;
Grieco, Antonio ;
Gasbarrini, Antonio ;
Villa, Erica ;
Zavaglia, Claudio ;
Bruno, Raffaele ;
Colombo, Massimo ;
Craxi, Antonio .
HEPATOLOGY, 2013, 57 (03) :1046-1054